Granules India Limited announced today that its US subsidiary has received approval from the Food and Drug Administration (FDA) for generic Bupropion Hydrochloride Extended-Release Tablets.

HYDERABAD: Pharma player Granules India Limited on Friday said it has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (FDA) for its Unit V facility ...

Nov 6 (Reuters) - Drugmaker Granules India (GRAN.NS), opens new tab reported a 4.8% fall in its second-quarter profit on Wednesday, dragged by a slow demand in the North American and European markets.

Granules India Ltd share price was down by -1.77% from the previous closing price of ₹572.30. Who are peers of Granules India Ltd? The peers of Granules India Ltd are Who is/are the promoter ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

According to Michigan State University and Penn State University Extension, granular and liquid fertilizers provide the same total amount of nutrients; the differences lie in crops’ access to ...

What is most remarkable about the technique is the relation between the triviality of the grain (heard alone it is the merest click or 'point' of sound) and the richness of the layered granular ...

Aditya Birla SL Pure Value Fund (G) 145.05 25,46,492 2.26 Aditya Birla SL Pure Value Fund (IDCW) 145.05 25,46,492 2.26 Aditya Birla SL Pure Value Fund - Direct (G ...

Granules India has received USFDA approval to market a generic medication for major depressive disorder, Bupropion Hydrochloride extended-release tablets USP (SR), expanding its presence in the US ...

The Quarterly Results page of Granules India Ltd. presents the key result items, its comparison with the sector peers and its previous 5 Quarterly Results.